MediWound Stock
MediWound Ltd.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Israel
- CEO
- Ofer Gonen
- Employees
- 121
- Market cap
- $153 M
- IPO
- 20/03/2014
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of…
MediWound stock: price history
1D
-2.9%
1W
-5.5%
1M
-10.4%
6M
-33.1%
YTD
-35.8%
1Y
-39.1%
2Y
-34.1%
5Y
-50.4%
10Y
-75.1%
Next earnings date
Next earnings date
19/11/2026 (in 33 days)
Volatility around earnings
~12% stronger price swings than usual
Ask the agents about MediWound
Analyst assessment of MediWound
PRICE TARGET LOW
US$27.00
CONSENSUS
US$28.50
MEDIAN
US$28.50
PRICE TARGET HIGH
US$30.00
0
STRONG BUY
13
BUY
0
HOLD
0
SELL
0
STRONG SELL
13
TOTAL · Buy
As of: 14/08/2026
MediWound stock metrics
P/E
-7.41
P/B
4.28
EV/EBITDA
-8.32
RETURN ON EQUITY
-20.7%
NET MARGIN
-239.1%
DEBT/EQUITY
0.27
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
74.5%
FLOAT SHARES
9,616,121
AVG. DAILY VOLUME (30D)
86,074
Insider transactions (SEC)
Rubinstein Samuel
Rubinstein Samuel
Hess Shmuel
Hess Shmuel
Hess Shmuel
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about MediWound stock
What does MediWound do?
MediWound Ltd. is a company in the Healthcare sector, Biotechnology industry, headquartered in Israel.
The CEO is Ofer Gonen, the company employs around 121 people.
The IPO was on 20/03/2014; the stock trades on NASDAQ under the ticker MDWD.
What do analysts say about MediWound stock?
13 analysts rate the stock, the consensus is Buy (as of 14/08/2026).
The average price target is US$28.50, ranging from US$27.00 to US$30.00, with a median of US$28.50.
This is an external assessment, not a statement by Market Jury.
When does MediWound report next?
The next earnings date is 19/11/2026.
Around past earnings, price swings were roughly 12% stronger than usual.
Does MediWound pay a dividend?
No, MediWound currently does not pay a dividend.
Which stocks are comparable to MediWound?
Comparable stocks include Alpha Tau Medical, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines and Incyte.
How can I get MediWound stock analyzed?
Clicking "Analyze stock" lets five strategies assess MediWound against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.